Tazarotene topical - Almirall S.A.
Alternative Names: AGN 190168 topical; AGN-190299; Avage; Fabior; Suretin; Tazorac; ZoracLatest Information Update: 05 Nov 2023
At a glance
- Originator Allergan
- Developer Mayne Pharma; Stiefel Laboratories
- Class Antiacnes; Antipsoriatics; Esters; Keratolytics; Nicotinic acids; Pyrans; Pyridines; Retinoids; Small molecules
- Mechanism of Action Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Acne; Psoriasis
Highest Development Phases
- Marketed Acne vulgaris; Photodamage; Psoriasis